Condition
Recurrent Supratentorial Glioblastoma clinical trials and research
Research outlook What's coming for Glioblastoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Recurrent Supratentorial Glioblastoma clinical trials that are recruiting, in United States. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Using Lerapolturev to treat recurrent glioblastoma after surgery
This study is testing a new treatment called lerapolturev for people with recurrent glioblastoma after surgery to see if it is safe and works better than the standard chemotherapy drug lomustine.
-
Engineered NK cells for treating recurrent glioblastoma
This study is testing a new type of immune cell treatment for people with recurrent glioblastoma to see if it's safe and how well it works against the tumor.
Related topics
Quick answers
How many Recurrent Supratentorial Glioblastoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.